Home/Filings/4/0001209191-23-056474
4//SEC Filing

Doran Howard JR 4

Accession 0001209191-23-056474

CIK 0001811115other

Filed

Nov 21, 7:00 PM ET

Accepted

Nov 22, 4:27 PM ET

Size

5.9 KB

Accession

0001209191-23-056474

Insider Transaction Report

Form 4
Period: 2023-11-20
Doran Howard JR
Chief Business Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2023-11-20+300,000300,000 total
    Exercise: $0.30Exp: 2033-11-19Ordinary Shares (300,000 underlying)
Footnotes (2)
  • [F1]The exercise price is 0.245 pounds sterling. The U.S. dollar equivalent of the exercise price is $0.304 using the Bank of England rate as of November 17, 2023 (1.00 pound sterling = $1.243).
  • [F2]One third (1/3rd) of the shares subject to the option award shall vest on September 1, 2024, and one eighth (1/8th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service.

Issuer

Renalytix plc

CIK 0001811115

Entity typeother

Related Parties

1
  • filerCIK 0001415965

Filing Metadata

Form type
4
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 4:27 PM ET
Size
5.9 KB